SCHEMBL10960

SCHEMBL10960

Cc1noc(-c2cc(C3(C(=O)O)CC3)ccc2-c2ccccc2)c1Nc1cccc(N2CCOCC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC3 O15438 1/20 0.40
ABCC4 O15439 1/20 0.40
ABCB11 O95342 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2C9 P11712 1/20 0.40
ABCB4 P21439 1/20 0.40
LPAR1 Q92633 1/20 0.40
ABCC2 Q92887 1/20 0.40
SLCO1B3 Q9NPD5 1/20 0.40
SLCO1B1 Q9Y6L6 1/20 0.40
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
KIF18A Q8NI77 7/20 0.36
IGF1R P08069 1/20 0.36
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10961 0.92 LPAR1 (0.44) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL10491 0.87 TYK2 (0.41) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL10084 0.87 LPAR1 (0.51) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL10448 0.82 LPAR1 (0.42) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL9956 0.81 LPAR1 (0.43) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL10112 0.81 CYP2C9 (0.41) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL9833 0.81 LPAR1 (0.41) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL11598 0.81 CYP2C9 (0.41) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL10274 0.81 CYP2C9 (0.41) ABCC3ABCC4ABCB11CYP2C8CYP2C9
SCHEMBL10003 0.80 TYK2 (0.39) ABCC3ABCC4ABCB11CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102770415-B Polycyclic compounds as lysophosphatidic acid receptor antagonists AMIRA PHARMACEUTICALS INC 2014-09-24 CN disclosed
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed